logo

Oncomed Pharmaceuticals Inc (OMED)



Trade OMED now with
  Date
  Headline
12/5/2018 8:11:35 AM Mereo BioPharma And OncoMed Announce Proposed Combination
10/20/2018 6:38:26 AM OncoMed Announces Interim Phase 1b Results For Navicixizumab And Paclitaxel Combination Therapy
9/24/2018 8:09:02 AM OncoMed Announces Publication Of Phase 1a Data Of Navicixizumab
8/2/2018 8:22:41 AM OncoMed Pharmaceuticals Q2 Net Loss Narrows To $4 Mln From $15.2 Mln Last Year
4/18/2018 9:03:22 AM OncoMed Presents Multiple Preclinical Abstracts Related To Immuno-Oncology Programs
4/9/2018 8:42:09 AM OncoMed To Present Multiple Preclinical Abstracts Related To Immuno-Oncology Programs At AACR
3/19/2018 8:33:27 AM OncoMed Appoints John Lewicki, As President, CEO And Member Of Board Of Directors